Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloproliferative Neoplasms/Myelofibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04328844
What this trial is testing

Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

Who this might be right for
Solid Tumor, AdultNon-Hodgkin Lymphoma, AdultNSCLC+2 more
iOnctura 210
Testing effectiveness (Phase 2)Study completedNCT02396134
What this trial is testing

Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+11 more
City of Hope Medical Center 61
Not applicableStudy completedNCT02953704
What this trial is testing

Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)

Who this might be right for
MPN (Myeloproliferative Neoplasms)
Incyte Corporation 1,469
Testing effectiveness (Phase 2)Looking for participantsNCT05980806
What this trial is testing

Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

Who this might be right for
MyelofibrosisModerate ThrombocytopeniaMild Thrombocytopenia
Karyopharm Therapeutics Inc 58
Not applicableNot Yet RecruitingNCT07518940
What this trial is testing

ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia

Who this might be right for
Myeloproliferative DiseasePolycythemia VeraThrombocythemia Essential+2 more
Carmen Fava 25
Early research (Phase 1)Active Not RecruitingNCT04041050
What this trial is testing

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

Who this might be right for
Myeloproliferative Neoplasm
AbbVie 85
Early research (Phase 1)Active Not RecruitingNCT05233618
What this trial is testing

Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)

Who this might be right for
MyelofibrosisChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia
Karen Ballen, MD 44
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Early research (Phase 1)Active Not RecruitingNCT06313593
What this trial is testing

Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasms
Incyte Corporation 37
Testing effectiveness (Phase 2)Study completedNCT00039416
What this trial is testing

Imatinib Mesylate in Treating Patients With Myelofibrosis

Who this might be right for
Chronic Myelomonocytic LeukemiaEssential ThrombocythemiaPolycythemia Vera+1 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01348490
What this trial is testing

Ruxolitinib (INCB018424) in Participants With Primary Myelofibrosis (PMF), Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis (PPV-MF)

Who this might be right for
MPN (Myeloproliferative Neoplasms)
Incyte Corporation 66
Early research (Phase 1)Study completedNCT00462761
What this trial is testing

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

Who this might be right for
Acute Myeloid LeukemiaLeukemiaMyelodysplastic Syndrome+2 more
Daiichi Sankyo 76
Not applicableActive Not RecruitingNCT04217356
What this trial is testing

Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis

Who this might be right for
MyelofibrosisHigh-Risk CancerBone Marrow Cancer
University Health Network, Toronto 90
Testing effectiveness (Phase 2)Looking for participantsNCT07394153
What this trial is testing

Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia

Who this might be right for
Myelofibrosis，MF
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas 30
Large-scale testing (Phase 3)Study completedNCT00799461
What this trial is testing

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Early research (Phase 1)Study completedNCT03566446
What this trial is testing

CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasm, UnclassifiableEssential ThrombocythemiaMyelofibrosis
Inge Marie Svane 10
Not applicableNo Longer AvailableNCT03592576
What this trial is testing

Expanded Access to Navitoclax

Who this might be right for
MyelofibrosisAcute Lymphocytic Leukemia (ALL)Lymphoblastic Lymphoma
AbbVie
Testing effectiveness (Phase 2)Ended earlyNCT06397313
What this trial is testing

RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis

Who this might be right for
Myelofibrosis
Ryvu Therapeutics SA 36
Early research (Phase 1)WithdrawnNCT04464889
What this trial is testing

HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMyelodysplastic Syndromes+5 more
Medigene AG
Next Page